WilsonHCG Only Provider to Be Named “Star Performer” Five Years Running in Everest Group's RPO Service Provider PEAK Matrix Assessment
WilsonHCG, global leader and premium provider of innovative talent solutions, has been named “2018 Recruitment Process Outsourcing (RPO) Market Star Performer” in Everest Group's PEAK Matrix™ Assessment. WilsonHCG is the only talent solutions provider to receive the recognition for five consecutive years – commended by Everest Group and buyers for its specialized total talent solutions offerings, strong technology recruitment practice, Empower ECOmetrics analytics platform to expand predictive capabilities, responsiveness, flexibility and reliable execution.
“WilsonHCG has been consistently outperforming the broader RPO market for several years, thus emerging as a Star Performer in the 2018 RPO PEAK Matrix Report,” said Arkadev Basak, Vice President at Everest Group. “WilsonHCG has achieved this growth by making the right set of investments in technology, bringing innovative solutions to the market, and expanding its presence and capabilities in new markets.”
Everest Group’s PEAK Matrix is the most trusted, fact-based analysis of service provider capabilities, covering more than 50 market segments each year. For the 2018 selections , Everest Group evaluated 21 established RPO service providers in the areas of vision and strategy; scope of services offered; innovation and investments; delivery footprint; market impact; as well as executive interviews and data collection from RPO buyers. The Star Performer title was based on the “greatest positive relative year-on-year movement on the PEAK Matrix in terms of market impact as well as vision and capability.”
"It's an honor to be named a 2018 RPO Market Star Performer for the fifth consecutive year," said John Wilson, Founder and CEO of WilsonHCG . “The honor reaffirms that WilsonHCG is delivering on the innovative solutions that we promise; with a laser focus on our clients’ successes and developing our people.”
WilsonHCG’s recognition as 2018 RPO Market Star Performer comes on the heels of being named a “Leader” in NelsonHall’s 2018 NEAT vendor evaluation for RPO , a top RPO provider in HRO Today’s Global Baker’s Dozen List for seven consecutive years, and to HRO Today’s EMEA Baker’s Dozen Customer Satisfaction List for the third consecutive year.
For additional insight into Everest Group's RPO PEAK Matrix™ Assessment 2018, or to learn more about WilsonHCG’s solution offerings, visit http://www.wilsonhcg.com .
WilsonHCG is the premium provider and global leader in innovative talent solutions, operating on the principle of providing true partnership to our clients. Through our integrated and highly configurable model – Talent Ecosystem™ – we enhance each client’s talent function into an employer of choice that drives strategic, business-impacting results. While optimizing clients' talent strategies is essential, WilsonHCG recognizes the relationships we develop lead to the results our clients realize. Better People, Better Business®
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
HENLEY-&-PARTNERS14.12.2018 15:02 | Pressemeddelelse
Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth
BOEHRINGER-INGELHEIM14.12.2018 10:09 | Pressemeddelelse
Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer
NV-ALPS-ELECTRIC14.12.2018 09:00 | Pressemeddelelse
Alps Electric to Exhibit at CES 2019 as Alps Alpine for the First Time
KALRAY14.12.2018 08:20 | Pressemeddelelse
Kalray Joins Autoware Foundation as Founding Premium Member
IDEMIA14.12.2018 04:32 | Pressemeddelelse
IDEMIA Provides Subscription Management Platform to dtac in Thailand to Offer eSIM Connected Watches to All Its Subscribers.
CO-CLOVIS-ONCOLOGY13.12.2018 18:48 | Pressemeddelelse
CHMP Grants Positive Opinion for New Indication of Clovis Oncology’s Rubraca®▼ (rucaparib) Tablets as Maintenance Treatment for Women with Relapsed Ovarian Cancer
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.Besøg vores nyhedsrum